Breaking News
July 16, 2018 - Quark Pharmaceuticals, Inc Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
July 16, 2018 - NSAIDs shown to have causal role in cardiovascular risk of patients with osteoarthritis
July 16, 2018 - PET scan tracer predicts success of cancer ‘vaccine’ | News Center
July 16, 2018 - Parents struggle with what to do when their child has headache, shows study
July 16, 2018 - Outrageous or overblown? HHS announces another round of ACA navigator funding cuts
July 16, 2018 - Weight loss surgery may impact individual’s risk of developing cancer, shows study
July 16, 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
July 16, 2018 - Restoring epigenetic balance reinstates memory in flies with Alzheimer’s disease symptoms
July 16, 2018 - Magnetized wire could be used to detect cancer in people | News Center
July 16, 2018 - Non-surgical management found to be feasible option for penetrating kidney trauma
July 16, 2018 - California clinic screens asylum seekers for honesty
July 16, 2018 - FDA Approves Xtandi (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
July 16, 2018 - Can nanotechnology help treat Alzheimer’s?
July 16, 2018 - Researchers identify protein essential for making stem cells | News Center
July 16, 2018 - Radiologist discusses causes, treatments of varicose veins
July 16, 2018 - Researchers develop nanostructured surface to accelerate wound healing after dental implants
July 16, 2018 - New non-invasive procedure to reposition kidney stones could benefit astronauts
July 16, 2018 - Attending Surgeon Influences Genetic Testing in Breast Cancer
July 16, 2018 - Medical doctors with addictions fear professional repercussions if they seek treatment
July 16, 2018 - 5 Questions: John Ioannidis calls for more rigorous nutrition research | News Center
July 16, 2018 - SUSU scientists develop rehabilitation device for people with lower limbs injuries
July 16, 2018 - Researchers find definite increase in scooter-related injuries
July 16, 2018 - Researchers solve mystery of final blood group system
July 16, 2018 - Researchers develop near-infrared fluorophores-based PDT to cure cancer with less side effects
July 16, 2018 - Traumatic brain injury biomarker could help predict patient prognosis
July 16, 2018 - Researchers to investigate role of hormones in mosquito’s ability to use human blood for egg production
July 16, 2018 - AHA: Doctor Makes Lifesaving House Call in His Own Home
July 16, 2018 - Nearsightedness – Genetics Home Reference
July 16, 2018 - Study shows biomarker panel boosts lung cancer risk assessment for smokers
July 16, 2018 - Researchers find link between bereavement during pregnancy, child’s mental health | News Center
July 16, 2018 - Legalizing same-sex marriage has meaningful effects on health care access for sexual-minority men
July 16, 2018 - New York to allow medical marijuana as substitute to opioids
July 16, 2018 - Reducing tapeworm infection could improve academic performance, reduce poverty | News Center
July 16, 2018 - Researchers describe key role of enzyme in regulating immune response against Chagas disease parasite
July 16, 2018 - Johnson & Johnson Announces Publication in The Lancet Highlighting Robust Immune Response to Janssen’s Mosaic-based Preventive Vaccine Regimen for HIV
July 16, 2018 - Do Racial and Gender Disparities Exist in Newer Glaucoma Treatments?
July 16, 2018 - Antibodies may predict transplant rejection risk
July 16, 2018 - New center sets out to stop disease before it starts | News Center
July 16, 2018 - FDA warns consumers about criminals sending fake warning letters
July 16, 2018 - Residential segregation linked with racial disparities in firearm homicide fatalities
July 16, 2018 - UW-Madison researchers develop new method to track Parkinson’s damage in the heart
July 16, 2018 - New approach to cultivate hypoallergenic tomato and strawberry varieties
July 16, 2018 - Smoking associated with delayed shinbone healing
July 16, 2018 - Sheila Dolezal, ‘team player extraordinaire,’ wins 2018 Amy J. Blue Award | News Center
July 16, 2018 - Advanced Prostate Cancer Variant More Common Than Thought
July 16, 2018 - New ways to conquer sleep apnea compete for place in bedroom
July 16, 2018 - Renowned microbe hunter Stanley Falkow dies at 84 | News Center
July 15, 2018 - FDA Slaps Stronger Warnings on Potent Class of Antibiotics, Fluoroquinolones
July 15, 2018 - Don’t let depression keep you from exercising
July 15, 2018 - Student research symposium showcases curiosity and scholarship | News Center
July 15, 2018 - Heavy smokers have increased risk of heart rhythm disorder, shows study
July 15, 2018 - Parents who had severe trauma, stresses in childhood more likely to have kids with behavioral health problems
July 15, 2018 - At colloquium, a range of views on value of predictive algorithms | News Center
July 15, 2018 - Pittcon invites oral and poster presentations for 2019 Technical Program
July 15, 2018 - Virtual reality could offer psychotherapy for fear of heights, study shows
July 15, 2018 - Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes
July 15, 2018 - Kolon TissueGene To Start US Phase III Clinical Trial For Invossa
July 15, 2018 - Study finds prenatal marijuana use can affect infant size, behavior
July 15, 2018 - Howard Chang named HHMI investigator | News Center
July 15, 2018 - Study shows tailored mental health services improve wellbeing of emerging adults
July 15, 2018 - A bright future might help teens steer clear of violence
July 15, 2018 - Stanford Medicine magazine explores the art, science of listening and hearing | News Center
July 15, 2018 - New study tracks how the brain turns simple sensory inputs into meaningful categories
July 15, 2018 - Deadlier subtype of metastatic prostate cancer found to be common than previously thought
July 15, 2018 - UZH scientists identify enzyme that controls cell division
July 15, 2018 - Unhealthy Food Behaviors May Signal Eating Disorder in Teen
July 15, 2018 - Study raises doubts on a previous theory of Parkinson’s disease
July 15, 2018 - Grant awarded to study whether stem cells can treat urinary incontinence | News Center
July 15, 2018 - Imaging techniques may help assess immune system recovery in HIV patients
July 15, 2018 - Machine-learning may aid in diagnosis and treatment of mental health disorders
July 15, 2018 - ‘Skin Cancer, Take A Hike!’ program promotes sun safety and skin cancer awareness
July 15, 2018 - Blink Health announces lowest prices for generic prescriptions through Blue Eagle Health
July 15, 2018 - New drug strategy can alleviate multiple behavioral, cellular deficiencies in FXS mouse model
July 15, 2018 - Georgia State professor receives federal grant to study virus similar to Ebola virus
July 15, 2018 - Quitting Smoking? Even a Little Exercise Can Help You Stay Slim
July 15, 2018 - DBS treatment may slow the progression of Parkinson’s tremor in early-stage patients
July 15, 2018 - 5 Questions: Luby on virus with potential to cause global pandemic | News Center
July 15, 2018 - Corn loses its cancer-fighting phenolic acids when processed into cornflakes
July 15, 2018 - Study uncovers possible link between iron loading, alcohol intake and mortality
July 15, 2018 - Molecular insights of NagA enzyme could help combat TB
TCT: Hybrid Revascularization Safe Mid-Term But Not Better … Yet

TCT: Hybrid Revascularization Safe Mid-Term But Not Better … Yet

image_pdfDownload PDFimage_print

DENVER — A hybrid surgery plus stenting procedure for multivessel coronary artery disease didn’t improve outcomes or cut residual ischemia compared with a purely surgical approach or stenting alone, a small head-to-head trial showed.

Residual ischemia at 12 months was found by single-photon emission CT (SPECT) in 6.4% of patients with left internal mammary artery grafting (LIMA) of the left anterior descending (LAD) coronary artery and drug-eluting stents for other blocked vessels compared with 6.7% of patients with coronary artery bypass grafting alone (CABG) alone and 7.9% of patients with drug-eluting stents (DESs) alone.

The 12-month freedom from major adverse cardiac and cerebral events events was 88.6% compared with 88.0% , and 86.8%, respectively among the arms, none of which differed significantly in the HREV trial.

Target vessel or graft failure was likewise similar across arms, at 11.5%, 12.0%, and 11.3%, respectively, Roman Tarasov, MD, PhD, of the State Research Institute for Complex Issues of Cardiovascular Diseases in Kemerovo, Russia, reported at a press conference here at the Transcatheter Cardiovascular Therapeutics meeting.

Press conference moderator Roxana Mehran, MD, of the Icahn School of Medicine at Mount Sinai in New York City, noted that the importance of this small study — really the first pilot study that has hybrid multivessel, PCI and CABG head-to-head — is in finding the hybrid approach is safe.

“Hybrid revascularization is something we talked about 2 decades ago. Because we knew — before drug-eluting stents came along — we knew the best therapy to LAD to protect the patient is LIMA … We know that vein grafts also don’t have the durability as a LIMA to the LAD. So the best of two worlds would be a LIMA to the LAD, and drug-eluting stents do extremely well in the non-LAD distribution, hence hybrid revascularization.”

While logistically challenging, she said, “I do believe there are a tremendous number of sites in the U.S. that have some appetite for this. Especially now with heart team approach now … we are having shared decisions with [patients] and the heart team to give them best of both worlds. But you have to prove this is the best possible treatment modality for these patients, which means long follow-up and good comparator arms.”

The Cardiothoracic Surgical Network’s Hybrid Coronary Revascularization Trial funded by the NIH should give the more definitive answer, said David Cohen, MD, of Saint Luke’s Mid-America Heart Center in America Heart Institute in Kansas City, Missouri, a press conference discussant.

“Really, the benefit of the LIMA is not the first year so much, it’s 10 years, 20 years. And I think it’s going to take something on that order to really show the benefit of this type of approach,” he said.

The trial included 150 patients randomized to the three treatment arms at a single Russian center. Left main and chronic total occlusion were excluded, as were other scenarios for which the three procedures weren’t deemed equally feasible.

Hybrid procedures were minimally-invasive, off-pump revascularization of the left anterior descending artery with the left internal mammary artery followed by consecutive percutaneous coronary intervention (PCI) in the rest of the arteries, done in two stages within 3 days. All PCI was done with the same second-generation Xience V and Xience Prime DES.

Nearly 10% of the hybrid group (five patients) required conversion to conventional on-pump CABG with a median sternotomy for surgical technical reasons (two cases) or due to hemodynamic instability following grafting in the absence of other lesion revascularization (three cases). However, there was less with BARC 3-4 bleeding than with CABG (9.6% versus 20.0%).

The trial was sponsored by the Russian Academy of Medical Sciences.

The researchers disclosed no relevant relationships with industry.

2017-10-31T12:23:36-0400

Tagged with:

About author

Related Articles